Ryuji Okuyama

发表

Phase I trial of Wilms' Tumor 1 (WT1) peptide vaccine with GM-CSF or CpG in patients with solid malignancy.

Masakazu Yamamoto, H. Sugiyama, S. Ohno, 2012, Anticancer research.

Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer

Masakazu Yamamoto, K. Takeda, R. Okuyama, 2013, Clinical Cancer Research.

Anti-CD137 Monoclonal Antibody Administration Augments the Antitumor Efficacy of Dendritic Cell-Based Vaccines

Fumito Ito, A. Chang, A. Shreiner, 2004, Cancer Research.

Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients

Masakazu Yamamoto, K. Takeda, T. Hatori, 2013, Oncoimmunology.

Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase

Masakazu Yamamoto, K. Hayashi, G. Nakajima, 2013, Gastric Cancer.

Effect of green tea extract on reactive oxygen species produced by neutrophils from cancer patients.

Masakazu Yamamoto, Katsuhiko Suzuki, Y. Ohno, 2012, Anticancer research.

Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab

K. Hayashi, K. Kawakami, G. Nakajima, 2017, Cancer Chemotherapy and Pharmacology.

Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer

Masakazu Yamamoto, K. Takeda, R. Okuyama, 2014, Journal of Translational Medicine.

Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer.

Masakazu Yamamoto, K. Hayashi, T. Hatori, 2011, Experimental and therapeutic medicine.